Skip to main content
. 2019 Mar 14;11:2129–2138. doi: 10.2147/CMAR.S184922

Figure 2.

Figure 2

Kaplan–Meier curves for iPFS in advanced EGFR-mutant NSCLC patients with various number of brain metastases.

Note: Patients with more than three brain metastases had significantly shorter median iPFS than those with three or less brain metastases (12.5 vs 18.0 months, P=0.044).

Abbreviations: iPFS, intracranial progression-free survival; NSCLC, non-small-cell lung cancer.